Myomo sells the MyoPro, a custom-fabricated arm brace that uses muscle signals to help people with partial arm paralysis move their arm and hand. MYO reports earnings on Mon, Nov 9, 2026.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Aug 27 | Ascendiant Capital | Target raised | Buy | |
| Jun 8 | Ascendiant Capital | Maintained | Buy |
Seasonality
How MYO has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2017.
Whale Options Flow
90DNo whale options trades in MYO in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether MYO is in one of them and how their past MYO trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered MYO in an article yet. Here's the latest on the wider market.
About Myomo
Myomo designs and sells the MyoPro, a custom-fabricated myoelectric arm brace that uses a user's own muscle signals to help support and move a weak or paralyzed arm and hand. Its customers are mainly adults and adolescents with neuromuscular conditions such as stroke, brachial plexus injury and spinal cord injury. The company sells directly to patients, billing their insurers, and also through orthotics and prosthetics providers, the Veterans Administration and some accounts overseas. It is based in Massachusetts.
- Headquarters
- Boston, MA